Drug intelligence / Profile preview

Vitrium

Development stage
Discontinued
Lead developer
Bio2 Technologies
Administration
Ophthalmic
01

Overview

Vitrium is a proprietary, resorbable orthobiomaterial composed entirely of bioactive glass (specifically 13-93 bioactive glass). Developed by Bio2 Technologies, it is designed for use in musculoskeletal reconstructive surgeries, such as spinal fusion, where it serves as a structural, load-bearing scaffold. The material features a unique porous structure that facilitates bone remodeling by allowing for the gradual conversion of the implant into the patient's own natural bone, a process referred to as Total Biologic Fusion (TBF). Unlike traditional implants made of PEEK or titanium, Vitrium is fully resorbable and osteoconductive, harnessing the body's regenerative processes to achieve fusion without leaving foreign materials behind. It has been evaluated in clinical trials as a cervical interbody fusion device for patients with symptomatic degenerative cervical disc disease.

Brand names
Vitrium
Other names
Vitrium Cervical Interbody DeviceVitrium OrthobiomaterialNovum Vitrium Cervical Cage

Beyond the preview

Go deeper on Vitrium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitrium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call